# First Affiliated Hospital of Wannan Medical College

Organization · id `cardio:org-first-affiliated-hospital-of-wannan-medical-college` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 05wbpaf14](<https://ror.org/05wbpaf14>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 05wbpaf14 by an exact name.

## The registry's words

- Sponsor name: First Affiliated Hospital of Wannan Medical College
- Sponsor class: OTHER
- ROR name: First Affiliated Hospital of Wannan Medical College

## Connected pages

- Sponsors: LLTS to Treat Premature Ventricular Contractions (`cardio:ct-nct04909528`)
- Sponsors: Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis (`cardio:ct-nct06225752`)
- Sponsors: Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial（HERO -aCKD） (`cardio:ct-nct07027774`)
- Sponsors: Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke (`cardio:ct-nct07501533`)
- Sponsors: Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease (`cardio:ct-nct07537088`)
- Sponsors: Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage (`cardio:ct-nct07642427`)
- Sponsors: Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. (`cardio:ct-nct07908875`)

## Provenance

Content hash: 9f58a6e39a3e80450854a5bfb8011c66be68d77a4b361847b81cadab658d5d09
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
